SickKids scientists lay the groundwork for early detection of cardiomyopathy

In the first study to use whole genome sequencing to examine tandem repeat expansions in heart conditions, scientists at The Hospital for Sick Children (SickKids) have laid the groundwork for early detection of and future precision therapies for cardiomyopathy.

Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T

A phase Ib/II study demonstrated that mosunetuzumab (Lunsumio) plus polatuzumab vedotin (Polivy) induced durable responses in patients with relapsed or refractory large B-cell lymphoma (LBCL),

January 12, 2024

How Hospitals Share Healthcare Data Can Cost Lives

Dan Torrens, CEO of eHealth Technologies Patient data interoperability sounds like industry jargon, but it’s a vital piece of providing timely and accurate patient care.

April 22, 2024

Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA) – Biotech Investments

EQS-News: Biotest AG / Key word(s): Regulatory Admission Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration

January 10, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.